Regencell Bioscience Holdings Limited

NasdaqCM RGC

Regencell Bioscience Holdings Limited Share Price on January 14, 2025: USD 4.86

Regencell Bioscience Holdings Limited Share Price is USD 4.86 on January 14, 2025, a -51.59% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.

Regencell Bioscience Holdings Limited 52-week high Share Price is USD 14.96 on July 23, 2024, which is 207.82% above the current Share Price.
Regencell Bioscience Holdings Limited 52-week low Share Price is USD 3.20 on July 16, 2024, which is -34.16% below the current Share Price.
Regencell Bioscience Holdings Limited average Share Price for the last 52 weeks is USD 6.09.

Key data

Date	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)

NasdaqCM: RGC

Regencell Bioscience Holdings Limited

CEO	Mr. Yat-Gai Au
IPO Date	July 16, 2021
Location	Hong Kong
Headquarters	First Commercial Building
Employees	12
Sector	Health Care
Industries Biotechnology Pharmaceuticals Research & Consulting

Description

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Key trends

Past 5 years